Beta Bionics (BBNX) Inventory (2023 - 2026)

Beta Bionics has disclosed Inventory across 4 years of filings, most recently posting $23.7 million for Q1 2026.

• Inventory for Q1 2026 came in at $23.7 million, up 50.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $23.7 million (up 50.84% YoY), and the FY2025 annual result was $21.7 million, up 63.08% from the prior year.
• Inventory came in at $23.7 million for Q1 2026 at Beta Bionics, up from $21.7 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $23.7 million in Q1 2026 to a low of $1.2 million in Q4 2023.
• The 4-year median for Inventory is $17.3 million (2025), against an average of $16.2 million.
• Across the five-year window, Inventory surged 969.88% in 2024 and soared 50.84% in 2026, its largest moves.
• Beta Bionics' Inventory stood at $1.2 million in 2023, then soared by 969.88% to $13.3 million in 2024, then surged by 63.08% to $21.7 million in 2025, then increased by 9.23% to $23.7 million in 2026.
• The last three Inventory figures came in at $23.7 million (Q1 2026), $21.7 million (Q4 2025), and $20.4 million (Q3 2025), per Business Quant data.